Obstet Gynecol Sci.  2023 Mar;66(2):76-83. 10.5468/ogs.22184.

Intraumbilical versus intramuscular oxytocin in the management of the third stage of labor

• Bu SW
• Alas-Pineda C
• Aguilar-Andino D
• Norwood DA
• Gaitán-Zambrano K
• Pinto-Romero M

• KMID: 2540476
• DOI: http://doi.org/10.5468/ogs.22184

Abstract

Objective
To compare the effect of intraumbilical vein oxytocin injection with standard management in reducing blood loss during the third and fourth stages of labor. Acute complications threaten the mother’s life during the third and fourth stages of labor. The most common complication is postpartum hemorrhage, which remains a leading cause of maternal mortality, particularly in developing countries.
Methods
A randomized controlled trial was conducted in the Gynecology and Obstetrics Department of Leonardo Martínez Valenzuela Hospital from January to June 2021. A probabilistic sample was used: 332 pregnant patients were enrolled in the study and randomized into the case (166 patients) and control (166 patients) groups. The volume of blood lost was compared between the groups.
Results
The median estimated blood loss was 120 mL (interquartile range [IQR], 80-218.75 mL). There was a statistically significant difference between the groups, showing less estimated blood loss in the international unit group with a median of 80 mL (IQR, 60-100 mL) (P<0.001), and 200 mL (IQR, 143.75-300 mL) in the intramuscular (IM) group, highlighting that 66.8% of the IM group had an estimated blood loss >251 mL.
Conclusion
Any reduction in bleeding during labor is clinically relevant because it improves patient prognosis. The use of intraumbilical oxytocin injection with active management of the third stage of labor significantly reduced postpartum blood loss and the duration of the third stage compared with the IM group.

Keyword

Oxytocin; Labor stage; third; Postpartum hemorrhage

Reference

References

1. Güngördük K, Asicioglu O, Besimoglu B, Güngördük OC, Yildirm G, Ark C, et al. Using intraumbilical vein injection of oxytocin in routine practice with active management of the third stage of labor: a randomized controlled trial. Obstet Gynecol. 2010; 116:619–24.

2. Menard MK, Main EK, Currigan SM. Executive summary of the reVITALize initiative: standardizing obstetric data definitions. Obstet Gynecol. 2014; 124:150–3.

3. Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014; 2:e323–33.

4. Mitchell C. PAHO/WHO initiative seeks to reduce maternal deaths from hemorrhage in countries of the America’s [Internet]. Washington: Panamerican Health Organization;c2015. [cited 2022 May 2]. Available from: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=10592:2015-pahowho-initiative-seeks-to-reduce-maternal-deaths-from-hemorrhage&Itemid=0&lang=en#gsc.tab=0 .

5. Sebghati M, Chandraharan E. An update on the risk factors for and management of obstetric haemorrhage. Womens Health (Lond). 2017; 13:34–40.

6. Gill P, Patel A, Van Hook JW. Uterine atony [Internet]. Treasure Island (FL): StatPearls Publishing;c2022. [cited 2022 May 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493238/ .

7. Breathnach F, Geary M. Uterine atony: definition, prevention, nonsurgical management, and uterine tamponade. Semin Perinatol. 2009; 33:82–7.

8. Makvandi S, Shoushtari SZ, Hosseini VZ. Management of third stage of labor: a comparison of intraumbilical oxytocin and placental cord drainage. Shiraz E-Med J. 1970; 14:83–90.

9. Mori R, Nardin JM, Yamamoto N, Carroli G, Weeks A. Umbilical vein injection for the routine management of third stage of labour. Cochrane database. Syst Rev. 2012; CD006176.

10. Harara R, Hanafy S, Zidan MS, Alberry M. Intraumbilical injection of three different uterotonics in the management of retained placenta. J Obstet Gynaecol Res. 2011; 37:1203–7.

11. Maiellano B, Hernández-Rojas PE. Alumbramiento dirigido con oxitocina intraumbilical. J Negat No Posit Results. 2020; 5:365–467.

12. Nankali A, Keshavarzi F, Fakheri T, Zare S, Rezaei M, Daeichin S. Effect of intraumbilical vein oxytocin injection on third stage of labor. Taiwan J Obstet Gynecol. 2013; 52:57–60.

13. Samanta A, Roy SG, Mistri PK, Mitra A, Pal R, Naskar A, et al. Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial. J Obstet Gynaecol Res. 2013; 39:75–82.

14. Maher MA, Sayyed TM, Elkhouly NI. Different routes and forms of uterotonics for treatment of retained placenta: a randomized clinical trial. J Matern Fetal Neonatal Med. 2017; 30:2179–84.

15. National Collaborating Centre for Women’s and Children’s Health (UK). Intrapartum care: care of healthy women and their babies during childbirth [Internet]. London (UK): RCOG Press;c2007. [cited 2022 May 15]. Available from:https://www.ncbi.nlm.nih.gov/books/NBK49388/ .

16. Martínez MM, López Farfán JA, Ramos Alvarez G, López Colombo A. Oxitocin trough umbilical vein to shorten the third stage of labor. Ginecol Obstet Mex. 2006; 74:89–94.

17. Shete GA, Pal SS, Pal YS, Shetty S. A comparative study between intra-umbilical vein injectionof oxytocin and intramuscular injection of oxytocin in thirdstage of labour. IOG. 2019; 9:5–8.

18. Gupta N, Athokpam M. Active management of third stage of labour: a comparative study of intra-umbilical oxytocin versus intramuscular oxytocin. Int J Reprod Contracept Obstet Gynecol. 2017; 6:3434–7.

19. Campero-Maneiro U, Santos-Bolívar J, Charry JA, Torres-Cepeda D, Reyna-Villasmil E, Mejía-Montilla J, et al. Inyección de oxitocina en la vena umbilical en el manejo activo del alumbramiento. MedULA. 2013; 22:10–5.

20. Puri M, Taneja P, Gami N, Rehan HS. Effects of different doses of intraumbilical oxytocin on the third stage of labor. Int J Gynaecol Obstet. 2012; 118:210–2.

21. Ghulmiyyah L, Wehbe S, Saltzman S, Ehleben C, Sibai B. Intraumbilical vein injection of oxytocin and the third stage of labor: randomized double-blind placebo trial. Am J Perinatol. 2007; 24:347–52.

22. Sharma I, Prabhakar M, Neerja RS. A comparative study of the efficacy of the intraumbilical & intravenous oxytocin in the management of third stage of labour. Int J Med Res Prof. 2018; 4:180–4.

23. Leduc D, Senikas V, Lalonde AB. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can. 2009; 31:980–93.